Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Return on Sales (2016 - 2025)

Cytokinetics (CYTK) has disclosed Return on Sales for 16 consecutive years, with 2.68% as the latest value for Q4 2025.

  • Quarterly Return on Sales changed N/A to 2.68% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.39% through Dec 2025, changed N/A year-over-year, with the annual reading at 7.47% for FY2025, 2270.0% down from the prior year.
  • Return on Sales for Q4 2025 was 2.68% at Cytokinetics, up from 92.0% in the prior quarter.
  • The five-year high for Return on Sales was 0.15% in Q2 2022, with the low at 573.91% in Q2 2024.
  • Average Return on Sales over 5 years is 109.4%, with a median of 68.52% recorded in 2022.
  • The sharpest move saw Return on Sales plummeted -42501bps in 2024, then soared 57208bps in 2025.
  • Over 5 years, Return on Sales stood at 0.65% in 2021, then crashed by -10492bps to 68.52% in 2022, then dropped by -17bps to 80.49% in 2023, then plummeted by -302bps to 323.39% in 2024, then soared by 99bps to 2.68% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 2.68%, 92.0%, and 1.84% for Q4 2025, Q3 2025, and Q2 2025 respectively.